Metformin 750mg PR Tablets

Metformin 750mg PR tablet is a prolonged-release biguanide treatment for type 2 diabetes. Gradual release can improve gastrointestinal tolerability for some people while supporting blood-glucose control.
Take the modified-release tablet with a meal and swallow it whole; do not crush or chew it. A tablet shell may occasionally be visible in the stool after the medicine has been released. Severe vomiting, diarrhoea or dehydration may require a temporary treatment pause because kidney function affects metformin clearance.
Metformin lowers hepatic glucose production, improves insulin sensitivity, and reduces intestinal glucose absorption to support type 2 diabetes control.
Possible effects include diarrhea, nausea, abdominal discomfort, metallic taste, reduced appetite, and low B12 with long-term use. Serious concerns include lactic acidosis, severe dehydration, allergic reaction, and hypoglycemia when combined with other diabetes medicines.
Tell your doctor about kidney or liver problems, dehydration, a severe infection, heart or lung failure, heavy alcohol use, pregnancy or breastfeeding. Mention planned contrast imaging or surgery, B12 deficiency risk, insulin, sulfonylureas and carbonic-anhydrase inhibitors such as topiramate. Kidney function affects whether metformin can be used safely.
Improves glucose and HbA1c control, has low hypoglycemia risk when used alone, and is often a foundation medicine in type 2 diabetes care.
Metformin 750mg is used to improve glucose control in type 2 diabetes.
Food can reduce nausea, diarrhea, and stomach discomfort.
No. Swallow the modified-release tablet intact; crushing or chewing can disrupt its release system.
Metformin safety depends on kidney clearance, and reduced kidney function can increase lactic acidosis risk.
Severe weakness, fast breathing, unusual sleepiness, vomiting, abdominal pain, dizziness, or feeling very cold need urgent review.
Metformin alone rarely causes hypoglycemia, but risk rises with insulin, sulfonylureas, missed meals, or heavy exercise.
Biguanide: the medicine class that includes metformin. Insulin sensitivity: how effectively body tissues respond to insulin. HbA1c: a marker of average glucose over roughly two to three months. Lactic acidosis: dangerous accumulation of lactic acid. Vitamin B12 deficiency: an inadequate B12 level that can affect blood cells and nerves.; AR: Metformin 750mg SR أقراص; FR: Metformin 750mg SR comprimé; PT: Metformin 750mg SR comprimido; ES: Metformin 750mg SR tableta; RU: Metformin 750mg SR таблетки; ID: Metformin 750mg SR tablet; VI: Metformin 750mg SR viên nén; MS: Metformin 750mg SR tablet; TL: Metformin 750mg SR tableta; ZH-SG: Metformin 750mg SR 片剂
International B2B Enquiry
Send a structured B2B enquiry for Metformin 750mg PR Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Metformin 750mg PR Tablets